Abstract
The invention pertains to a pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes having the ability to survive within macrophages of the animal, comprising live bacteria of a nocardioform actinomycetes species, the live bacteria being attenuated by inactivation of a gene that encodes a protein involved in methylhexahydroindanedione propionate degradation, and a pharmaceutically acceptable carrier for these live bacteria.
Original language | English |
---|---|
Patent number | WO2010079224 |
Priority date | 12/01/2009 |
Filing date | 15/07/2010 |
Publication status | Published - 15-Jul-2010 |